These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 7662605)
1. Evaluation of neopterin as a marker for restenosis following percutaneous transluminal coronary angioplasty. Eber B; Schumacher M; Tatzber F; Kaufmann P; Luha O; Esterbauer H; Gasser R; Klein W Cardiovasc Drugs Ther; 1995 Apr; 9(2):361-2. PubMed ID: 7662605 [No Abstract] [Full Text] [Related]
2. Fibrinogen values in patients with and without restenosis following percutaneous transluminal coronary angiography. Schumacher M; Eber B; Tiran A; Toplak H; Luha O; Gasser R; Klein W Cardiology; 1992; 80(5-6):345-8. PubMed ID: 1451121 [TBL] [Abstract][Full Text] [Related]
3. Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis). Hermans WR; Foley DP; Rensing BJ; Serruys PW Am Heart J; 1994 Mar; 127(3):483-94. PubMed ID: 8122593 [TBL] [Abstract][Full Text] [Related]
5. Homocysteine, lipoprotein(a), and restenosis after percutaneous transluminal coronary angioplasty: a prospective study. Miner SE; Hegele RA; Sparkes J; Teitel JM; Bowman KA; Connelly PW; Banijamali H; Lau HK; Chisholm RJ; Babaei S; Strauss BH Am Heart J; 2000 Aug; 140(2):272-8. PubMed ID: 10925342 [TBL] [Abstract][Full Text] [Related]
6. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis. Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915 [TBL] [Abstract][Full Text] [Related]
7. Lipids and fatty acids and their relationship to restenosis. Foley JB; Younger K; Foley D; Kinsella A; Molloy M; Crean PA; Gearty G; Gibney M; Walsh MJ Cathet Cardiovasc Diagn; 1992 Jan; 25(1):25-30. PubMed ID: 1555223 [TBL] [Abstract][Full Text] [Related]
8. Routine lipid profile in patients with and without restenosis after percutaneous transluminal coronary angioplasty. Schumacher M; Eber B; Toplak H; Klein W Am J Cardiol; 1992 Dec; 70(20):1640. PubMed ID: 1466350 [No Abstract] [Full Text] [Related]
9. Restenosis rate after multiple percutaneous transluminal coronary angioplasty procedures at the same site. A quantitative angiographic study in consecutive patients undergoing a third angioplasty procedure for a second restenosis. Bauters C; Mc Fadden EP; Lablanche JM; Quandalle P; Bertrand ME Circulation; 1993 Sep; 88(3):969-74. PubMed ID: 8353924 [TBL] [Abstract][Full Text] [Related]
10. Association of an acute reduction in lipoprotein(a) with coronary artery restenosis after percutaneous transluminal coronary angioplasty. Horie H; Takahashi M; Izumi M; Takaoka A; Fujita T; Sakamoto T; Kito O; Okamura H; Kinoshita M Circulation; 1997 Jul; 96(1):166-73. PubMed ID: 9236431 [TBL] [Abstract][Full Text] [Related]
11. Serum lipids and restenosis after successful percutaneous transluminal coronary angioplasty. Ichilov Magnesium Study Group. Roth A; Eshchar Y; Keren G; Sheps D; Kerbal S; Laniado S; Miller HI; Rubinstein A Am J Cardiol; 1994 Jun; 73(16):1154-8. PubMed ID: 8203331 [TBL] [Abstract][Full Text] [Related]
12. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups. Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901 [TBL] [Abstract][Full Text] [Related]
13. Effect of serum lipid concentrations on restenosis after successful de novo percutaneous transluminal coronary angioplasty in patients with total cholesterol 160 to 240 mg/dl and triglycerides < 350 mg/dl. Dzavik V; Teo KK; Yokoyama S; Modi R; Dinwoodie A; Burton JR; Tymchak WJ; Montague TJ Am J Cardiol; 1995 May; 75(14):936-8. PubMed ID: 7733005 [No Abstract] [Full Text] [Related]